AlphaStocks

BIO vs MTD

As of Sep 20, 2026, Bio-Rad Laboratories (BIO) scores 7.4/10 and Mettler Toledo International (MTD) 5.5/10 on AlphaStocks' five-model composite, so BIO scores higher. MTD trades 21% above its model fair value.

BIO

BIO-RAD LABORATORIES, INC.

7.4

Consider Buy

$375.68

MTD

METTLER TOLEDO INTERNATIONAL INC/

5.5

Consider Buy

$1,393.14

BIO vs MTD: Which is the Better Investment?

BIO-RAD LABORATORIES, INC. (BIO) scores 7.4/10 while METTLER TOLEDO INTERNATIONAL INC/ (MTD) scores 5.5/10 on AlphaStocks' composite model. BIO-RAD LABORATORIES, INC. has the higher composite rating of Consider Buy. On a P/E basis, BIO-RAD LABORATORIES, INC. trades at 13.5x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricBIOMTD
Scores & Fundamentals
Composite Score7.4/105.5/10
RatingConsider BuyConsider Buy
Price$375.68$1,393.14
P/E Ratio13.533.1
ROE9.7%-8.9%
Market Cap$10B$28B
Fair Value$1,149.32
Dividend Yield
Sector Rank#7 of 168#76 of 168
Model Verdicts
PiotroskiAttractiveAttractive
BuffettNeutralNeutral
GrahamAttractiveNeutral
LynchAttractiveNeutral
GreenblattStrongNeutral
View full BIOanalysis →View full MTDanalysis →

Related comparisons

Compare any two stocks →

BIO vs MTD: Which Stock Scores Higher?

BIO-RAD LABORATORIES, INC. (BIO) and METTLER TOLEDO INTERNATIONAL INC/ (MTD) are both in the Health Care sector. BIO currently leads with a composite score of 7.4/10 (Consider Buy) compared to MTD's 5.5/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer